Chemoinformaics analysis of (+)-ISOTYLOCREBRINE
| Molecular Weight | 393.483 | nRot | 4 |
| Heavy Atom Molecular Weight | 366.267 | nRig | 25 |
| Exact Molecular Weight | 393.194 | nRing | 5 |
| Solubility: LogS | -3.662 | nHRing | 2 |
| Solubility: LogP | 4.088 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 3 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 27 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 24 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 16 |
| nHA | 5 | APOL | 62.3914 |
| nHD | 0 | BPOL | 35.7406 |
| QED | 0.608 |
| Synth | 3.021 |
| Natural Product Likeliness | 0.687 |
| NR-PPAR-gamma | 0.033 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.911 |
| Pgp-sub | 0.959 |
| HIA | 0.002 |
| CACO-2 | -5.032 |
| MDCK | 0.0000284 |
| BBB | 0.951 |
| PPB | 0.747223 |
| VDSS | 1.316 |
| FU | 0.117992 |
| CYP1A2-inh | 0.347 |
| CYP1A2-sub | 0.986 |
| CYP2c19-inh | 0.074 |
| CYP2c19-sub | 0.946 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.816 |
| CYP2d6-inh | 0.912 |
| CYP2d6-sub | 0.93 |
| CYP3a4-inh | 0.053 |
| CYP3a4-sub | 0.922 |
| CL | 9.558 |
| T12 | 0.395 |
| hERG | 0.822 |
| Ames | 0.568 |
| ROA | 0.892 |
| SkinSen | 0.932 |
| Carcinogencity | 0.117 |
| EI | 0.014 |
| Respiratory | 0.964 |
| NR-Aromatase | 0.732 |
| Antiviral | Yes |
| Prediction | 0.707031 |